Antiproliferative Activities and SwissADME Predictions of Physicochemical Properties of Carbonyl Group‐Modified Rotenone Analogues
Open Access
- 17 August 2023
- journal article
- research article
- Published by Wiley in ChemistryOpen
- Vol. 13 (1) , e202300087
Abstract
Rotenone is a naturally occurring compound shown to exhibit antiproliferative activity against various cancer cell lines, indicating its potential as a lead anticancer agent. However, its toxicity against normal cells has prompted further investigation and chemical modifications. In this study, a library of carbonyl group‐modified rotenone derivatives was synthesized and evaluated for their antiproliferative activities against MCF‐7 breast cancer cells, A549 human lung carcinoma cells, and HCT116 human colorectal cancer cells using 3‐(4, 5‐dimethylthiazolyl‐2)‐2, 5‐diphenyltetrazolium bromide (MTT) assay. The results showed several promising compounds that inhibited cell proliferation. Specifically, the oxime and alcohol rotenone derivatives exhibited antiproliferative activities against all 3 cancer cell lines, while the ethoxy, carbamate, and alkene derivatives are selective against MCF‐7 (IC50=5.72 μM), HCT116 (IC50=8.86 μM), and A549 (IC50=0.11 μM), respectively. SwissADME analysis showed that the physicochemical properties and drug‐likeness of the synthesized rotenone derivatives were within the set limits, suggesting the favorable characteristics of these compounds for drug development. The findings obtained in this work highlight the potential of rotenone derivatives as promising chemotherapeutic candidates.Keywords
This publication has 53 references indexed in Scilit:
- Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and SafetyChemical Research in Toxicology, 2011
- Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studiesBioorganic & Medicinal Chemistry Letters, 2010
- Rotenone induces apoptosis in MCF‐7 human breast cancer cell‐mediated ROS through JNK and p38 signalingMolecular Carcinogenesis, 2009
- Defining optimum lipophilicity and molecular weight ranges for drug candidates—Molecular weight dependent lower logD limits based on permeabilityBioorganic & Medicinal Chemistry Letters, 2009
- Physiochemical drug properties associated with in vivo toxicological outcomesBioorganic & Medicinal Chemistry Letters, 2008
- Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanismJournal of Cell Biology, 2006
- The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF- B pathwayCarcinogenesis, 2006
- Derrisin, a New Rotenoid from Derris malaccensis Plain and Anti-Helicobacter pylori Activity of Its Related ConstituentsJournal of Natural Products, 2002
- Drugs as P-glycoprotein substrates, inhibitors, and inducersDrug Metabolism Reviews, 2002
- 553. The absolute configuration of rotenoneJournal of the Chemical Society (Resumed), 1961